Clinical Trials Logo

Clinical Trial Summary

A study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD1705 in participants with dyslipidemia.


Clinical Trial Description

This is a first time in human study in male and female (of non-childbearing potential) participants with dyslipidemia. The study consists of two parts: 1. Part A (single ascending dose): Part A of the study will include three parts: A1 for non-Asian participants, A2 for Japanese participants, and A3 for Chinese participants. Parts A2 and A3 are optional. 2. Part B (multiple ascending dose): Part B of the study will include three parts: B1 for non-Asian participants receiving moderate- or high-intensity statin therapy, B2 for Japanese participants not receiving statin therapy, and B3 for participants who are receiving moderate- or high-intensity statin therapy, with the additional diagnosis of type 2 diabetes (T2D), and with HbA1c < 7.5%. Parts B2 and B3 are optional. The study will comprise of: - A Screening Period of maximum 60 days for both Part A and Part B. - Part A: A single dose of AZD1705 with an in-clinic period of 3 days. - An outpatient Follow-up Period of approximately 16 weeks. - Part B: 2 doses of AZD1705, given 28 days apart with an in-clinic period. - An outpatient Follow-up Period of approximately 20 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06238466
Study type Interventional
Source AstraZeneca
Contact AstraZeneca Clinical Study Information Center
Phone 1-877-240-9479
Email information.center@astrazeneca.com
Status Recruiting
Phase Phase 1
Start date January 16, 2024
Completion date September 9, 2025

See also
  Status Clinical Trial Phase
Completed NCT03236363 - Effectiveness of MOVI Interventions on Adiposity, Cognition and Motor Competence: MOVI-da10! N/A
Completed NCT03236337 - Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit! N/A
Completed NCT01304641 - Cardiovascular Events Based On Statin Initiation In The Elderly
Terminated NCT03277183 - Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Phase 4
Not yet recruiting NCT05316025 - Cardiovascular Digital Health Data Observatory
Completed NCT03170193 - AMG 529 First in Human Study Phase 1
Recruiting NCT05775484 - Exercise to Slow Cardiovascular Ageing Progression
Active, not recruiting NCT05085275 - Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Phase 3
Completed NCT04863040 - The Impact of Activity Breaks on Cognitive Function, Adiposity and Fitness in Preschoolers N/A
Not yet recruiting NCT04866732 - Physical Activity Program for Cardiac Health Among Older African American Populations N/A
Recruiting NCT05568966 - Collection of Blood Samples for New Diagnostic Devices 2 N/A
Recruiting NCT01820598 - Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients N/A
Completed NCT00824330 - Home-Based Walking Study in Older Adults With Type 2 Diabetes N/A
Completed NCT00387452 - Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 Diabetes N/A
Recruiting NCT05249296 - The Impact of Green Spaces on the General Well-being and Stress of Students N/A
Completed NCT01232309 - Effects of Chitin-Glucan on Oxidized Low-Density Lipoprotein (LDL) N/A
Completed NCT01489696 - A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin Phase 1
Completed NCT00954902 - Effects of Antioxidants on Cardiovascular Risk Measures (Spice Study) N/A
Completed NCT04216238 - Association of Wearable Activity Monitors With Post-Operative Activity Level Among Cardiovascular Surgical Patients
Completed NCT04121416 - Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery N/A